MapLight Therapeutics, Inc. · 9 hours ago
Join Our Talent Community
Maximize your interview chances
BiopharmaBiotechnology
Insider Connection @MapLight Therapeutics, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Company
MapLight Therapeutics, Inc.
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
Funding
Current Stage
Growth StageTotal Funding
$268.1MKey Investors
Michael J. Fox Foundation
2023-10-30Series C· $225M
2021-03-10Series Unknown· $30M
2020-11-30Grant· $8.1M
Recent News
2024-05-05
Company data provided by crunchbase